Correlation Between Rezolute and Cullinan Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rezolute and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Cullinan Oncology LLC, you can compare the effects of market volatilities on Rezolute and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Cullinan Oncology.

Diversification Opportunities for Rezolute and Cullinan Oncology

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Rezolute and Cullinan is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Rezolute i.e., Rezolute and Cullinan Oncology go up and down completely randomly.

Pair Corralation between Rezolute and Cullinan Oncology

Given the investment horizon of 90 days Rezolute is expected to generate 0.99 times more return on investment than Cullinan Oncology. However, Rezolute is 1.01 times less risky than Cullinan Oncology. It trades about -0.16 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.24 per unit of risk. If you would invest  487.00  in Rezolute on September 18, 2024 and sell it today you would lose (43.00) from holding Rezolute or give up 8.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rezolute  vs.  Cullinan Oncology LLC

 Performance 
       Timeline  
Rezolute 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Rezolute is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Rezolute and Cullinan Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rezolute and Cullinan Oncology

The main advantage of trading using opposite Rezolute and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.
The idea behind Rezolute and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world